What is Tom Brady's new role at eMed?

Tom Brady is the new Chief Wellness Officer at eMed, a digital health platform.

How does eMed help with weight loss drugs?

eMed provides solutions for companies to manage costs and improve employee access to weight loss medications like GLP-1s.

Why is access to weight loss drugs like Wegovy difficult?

Access is limited because employers often cite the high cost of these medications as a reason not to cover them.

Home / Business and Economy / Brady Tackles Health: New Role at Weight-Loss Platform

Brady Tackles Health: New Role at Weight-Loss Platform

12 Jan

•

Summary

Tom Brady is the new chief wellness officer at eMed.
eMed offers solutions for employers covering weight loss drugs.
Millions use GLP-1s, but access remains a significant barrier.

Brady Tackles Health: New Role at Weight-Loss Platform

NFL legend Tom Brady has stepped into a new role as Chief Wellness Officer at eMed, a digital health startup. This platform focuses on providing weight loss solutions and assisting companies in managing the significant expenses associated with weight loss medications for their employees. Brady's involvement aims to elevate the company's profile in the competitive telehealth market.

Brady expressed his commitment to eMed's mission, highlighting its focus on high-quality care, prevention, and long-term health. Millions have turned to GLP-1 drugs like Wegovy and Zepbound for weight management, but access remains a challenge, with only about 43 percent of large companies currently covering these medications due to their high cost.

eMed seeks to address this by offering innovative, cost-saving solutions to employers, thereby enabling broader employee access to these popular treatments. The company also provides a monthly subscription service connecting individuals with doctors for prescriptions and comprehensive health programs aimed at sustainable change.